In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to Ron Heeren, a speaker at the 2023 James L. Waters Symposium. Please could you introduce yourself, and tell us ...

Bayer, a leading company in key areas of radiology and cardiology, and Attralus, Inc. (Attralus), a clinical stage biopharmaceutical company focused on developing medicines and diagnostics for ...

Reston, VA—A newly published literature review sheds light on how nuclear medicine brain imaging can help evaluate the biological changes that cause chemotherapy-related cognitive impairment (CRCI), ...

Case Western Reserve University is a world leader in developing novel biomedical imaging technologies for translational and basic science applications. Research programs in imaging serve as the ...

A new fluorescent imaging probe can for the first time objectively and non-invasively measure loss of smell, clinically known as anosmia. Targeting the olfactory nerve, the new tool has potential to ...

Genomic and tumor microenvironment dynamics of brain metastases in breast cancer. ACE-Breast-02: A pivotal phase II/III trial of ARX788, a novel anti-HER2 antibody-drug conjugate (ADC), versus ...

The need to improve the detection of breast cancer in women with dense breasts has resulted in the use of additional imaging modalities to supplement screening. Supplemental molecular breast imaging ...

My laboratory concentrates on research related to the development and application of Molecular Imaging technologies. Specifically, we are interested in designing novel imaging tools to image ...

NEW ORLEANS (June 23, 2025)—The Society of Nuclear Medicine and Molecular Imaging (SNMMI) recognized seven new Fellows today during a plenary session at the society’s 2025 Annual Meeting, held June 21 ...

Director of Molecular Imaging and Therapy, Fred Hutch Wil B. Nelp, MD Endowed Professorship in Nuclear Medicine; Professor, Department of Radiology, University of Washington School of Medicine My ...